Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight

Summary

DelveInsight reports that the global oncology-based in-vivo CRO market is experiencing robust growth, projected to expand at approximately 8% CAGR through 2034, driven by increased cancer burden and rising demand for outsourced preclinical oncology research services.